Rare BCR::ABL1 Fusion Gene in Chronic Myeloid Leukaemia: A Case Report
Oncology Advances · 2024
DOI: 10.14218/ona.2023.00040 ↗Kurz gefasst
Fallbericht in der Zeitschrift Oncology Advances, 2024. Verfasst von Ruddy Dalfeor und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Chronic myeloid leukemia with a BCR::ABL1 b2a3 transcript is difficult to detect by conventional polymerase chain reaction (PCR). This can result in an incorrect diagnosis. We report a man with typical features of chronic myeloid leukemia but with a negative conventional PCR test for BCR::ABL1 in whom we identified a BCR::ABL1 fusion gene by fluorescence in situ hybridization and PCR with custom BCR and ABL1 primers.
Zitieren
APA
Dalfeor, R., Tavares, D. D. O., Bendit, I., Nardinelli, L., Tabak, D. G., & Gale, R. P. (2024). Rare BCR::ABL1 Fusion Gene in Chronic Myeloid Leukaemia: A Case Report. Oncology Advances. https://doi.org/10.14218/ona.2023.00040
Vancouver
Dalfeor R, Tavares DDO, Bendit I, Nardinelli L, Tabak DG, Gale RP. Rare BCR::ABL1 Fusion Gene in Chronic Myeloid Leukaemia: A Case Report. Oncology Advances. 2024. doi:10.14218/ona.2023.00040
BibTeX
@article{Dalfeor2024,
author = {Dalfeor, Ruddy and Tavares, Danilo de Oliveira and Bendit, Israel and Nardinelli, Luciana and Tabak, Daniel Goldberg and Gale, Robert Peter},
title = {Rare BCR::ABL1 Fusion Gene in Chronic Myeloid Leukaemia: A Case Report},
journal = {Oncology Advances},
year = {2024},
doi = {10.14218/ona.2023.00040}
}
EUVIMED